Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Dec 6:6:1475-503.
doi: 10.1100/tsw.2006.236.

New frontiers in the treatment of multiple myeloma

Janice Jin Hwang  1 , Irene M Ghobrial, Kenneth C Anderson
Affiliations
Review

New frontiers in the treatment of multiple myeloma

Janice Jin Hwang et al. ScientificWorldJournal. .

Abstract

Recent leaps in elucidating the biology of myeloma, particularly the intracellular pathways and the complex interaction with the bone marrow microenvironment, have resulted in an unprecedented surge of novel, targeted therapies and therapeutic regimens. There are currently over 30 new agents being tested in the treatment of multiple myeloma (MM). Many of these are novel, targeted agents that have demonstrated significant efficacy and prolonged survival. In this review, we summarize the current understanding of the mechanisms of action of novel therapies being tested in the preclinical and clinical settings in MM. These include agents that act directly on the intracellular signaling pathways, cell maintenance processes, and cell surface receptors. Finally, we present the clinical responses to some of these agents when used alone or in combination in clinical trials of patients with MM. Indeed, MM has become a model disease for the development of novel, therapeutic agents.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. N Engl J Med. 2004 Jun 3;350(23):2335-42 - PubMed
    1. J Clin Oncol. 2004 Aug 15;22(16):3269-76 - PubMed
    1. Blood. 2001 Aug 1;98(3):805-13 - PubMed
    1. Blood. 2004 May 1;103(9):3271-7 - PubMed
    1. Oncogene. 2003 Nov 20;22(52):8386-93 - PubMed

Publication types

MeSH terms